Drug Profile
852A
Alternative Names: 3M-852A; 852; PF-04878691; PF-4878691; S-32865Latest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator 3M Drug Delivery Systems
- Developer Kindeva Drug Delivery; Masonic Cancer Center; Pfizer
- Class Amines; Antineoplastics; Antivirals; Imidazoles; Quinolines; Skin disorder therapies; Small molecules; Sulfonamides
- Mechanism of Action Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Skin disorders
- Discontinued Barrett's oesophagus; Haematological malignancies; Hepatitis C; Malignant melanoma; Solid tumours
Most Recent Events
- 28 May 2019 No recent reports of development identified for phase-I development in Skin-disorders in USA (Topical)
- 29 Apr 2016 Chemical structure information added
- 26 Apr 2016 852 is available for licensing as of 26 Apr 2016. http://www.3m.com/3M/en_US/drug-delivery-systems-us/